📰 John Power News
Page 39 - John Power News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Power. Real-time updates on events, politics, business and more.
December 28, 2021
Road Safety Authority concerned about number of road deaths over Christmas
December 24, 2021
Reliving Mary Eshbaugh Hayes’ encounter with the Prince of Pop Art from the Sept. 3, 1981, issue of The Aspen Times.
December 23, 2021
/PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma ("Nuance"), a specialty care...
December 23, 2021
/PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma ("Nuance"), a specialty care...
December 23, 2021
Reliving Mary Eshbaugh Hayes’ encounter with the Prince of Pop Art from the Sept. 3, 1981 issue of The Aspen Times.
December 22, 2021
"The first thing I wanted to do when I got home was go down to the local and meet all the others who had come back to see what they’d been up to." Part of a series of Extraordinary Stories curated by bestselling author, historian, and podcaster Turtle Bunbury, ‘Half the Joy of Christmas’ tells the story of John Power.
December 14, 2021
Two biotech companies are joining the fight against COVID-19 with their collaborative work on an inhalable COVID-19 vaccine. The Chinese company CanSino Bi | Drug Discovery And Development
December 13, 2021
CanSino and Aerogen are teaming up to develop and market an inhaled version of CanSino's recombinant COVID-19 shot Convidecia, which is already approved in China as a one-and-done injectable. Because aerosol delivery requires a "considerably smaller volume of vaccine," the partners' inhaled prospect could help stretch capacity and enable more patients to access the inoculation, the companies said.
December 9, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 9, 2021
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology.